- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 497/08 - Bridged systems
Patent holdings for IPC class C07D 497/08
Total number of patents in this class: 21
10-year publication summary
|
1
|
1
|
2
|
1
|
2
|
0
|
2
|
1
|
2
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Otsuka Pharmaceutical Co., Ltd. | 1501 |
4 |
| Incyte Corporation | 1072 |
3 |
| Tokyo Ohka Kogyo Co., Ltd. | 1560 |
3 |
| Boehringer Ingelheim International GmbH | 4493 |
1 |
| President and Fellows of Harvard College | 6091 |
1 |
| The United States of America as represented by the Secretary of the Army | 1256 |
1 |
| Chugai Seiyaku Kabushiki Kaisha | 1422 |
1 |
| JNC Corporation | 1548 |
1 |
| JNC Petrochemical Corporation | 329 |
1 |
| Kuraray Co., Ltd. | 3589 |
1 |
| Sichuan Haisco Pharmaceutical Co., Ltd. | 151 |
1 |
| The United States of America, as represented by the Secretary, Dept. of Health & Human Services | 9 |
1 |
| Xenon Pharmaceuticals Inc. | 196 |
1 |
| H. Lundbeck A/S | 1231 |
1 |
| Other owners | 0 |